NAVCO Pharmaceuticals Inc.

TSXV:NAV Stock Report

Market Cap: CA$1.7m

NAVCO Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Geoffrey Lee

Chief executive officer

CA$62.8k

Total compensation

CEO salary percentage71.7%
CEO tenure11.1yrs
CEO ownershipn/a
Management average tenure1.1yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Geoffrey Lee's remuneration changed compared to NAVCO Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-CA$2m

Sep 30 2023CA$63kCA$45k

-CA$2m

Compensation vs Market: Geoffrey's total compensation ($USD46.10K) is below average for companies of similar size in the Canadian market ($USD176.25K).

Compensation vs Earnings: Insufficient data to compare Geoffrey's compensation with company performance.


CEO

Geoffrey Lee

11.1yrs

Tenure

CA$62,775

Compensation

Mr. Geoffrey Lee is Chief Executive Officer of NAVCO Pharmaceuticals Inc. from April 13, 2013.


Leadership Team

NamePositionTenureCompensationOwnership
Geoffrey Lee
Chief Executive Officer11.1yrsCA$62.78kno data
Christopher Cooper
Chief Financial Officer1.1yrsCA$31.60kno data
Marek Jasinski
COO & Director1.1yrsCA$72.00kno data
Thomas Jusdanis
Corporate Secretary & Independent Director1.1yrsCA$55.53kno data

1.1yrs

Average Tenure

52yo

Average Age

Experienced Management: NAV's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Marek Jasinski
COO & Director1.1yrsCA$72.00kno data
Thomas Jusdanis
Corporate Secretary & Independent Director1.1yrsCA$55.53kno data
Jatinder Dhaliwal
Independent Directorless than a yearno data9.2%
CA$ 157.5k
Judy Su
Independent Directorless than a yearno datano data

0.7yrs

Average Tenure

46yo

Average Age

Experienced Board: NAV's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.